Skip to content

Early Postoperative Intervention in Gastric Cancer Patients

Early Postoperative Structured Intervention for Quality of Life and Prognosis in Gastric Cancer Patients After Neoadjuvant Therapy:: A Multicenter,Open Label Randomized Controlled Trial

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07444099
Enrollment
264
Registered
2026-03-02
Start date
2026-02-10
Completion date
2027-06-30
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer (GC), Postoperative Recovery

Keywords

gastric cancer, postoperative care, postoperative complications, recover quality

Brief summary

This study was conducted by Qilu Hospital and five other renowned medical centers, aiming to evaluate the impact of early structured postoperative intervention on quality of life and prognosis in patients with gastric cancer after neoadjuvant therapy.

Detailed description

Investigators are conducting a two-arm, multicenter, interventional study at Qilu Hospital of Shandong University and five other renowned hospitals in China. A total of 264 gastric cancer patients who have completed preoperative neoadjuvant therapy will be randomly assigned to either the control group or the experimental group.For control group,patients will receive standard ERAS discharge management, including routine discharge education; outpatient follow-up visits on postoperative day 7 and postoperative day 30; and emergency contact via hospital telephone or emergency department visits for urgent situations.For experimental group,in addition to standard ERAS discharge management, patients will receive multimodal structured interventions during follow-up visits targeting nutritional status, psychological status, and exercise status. Nutritional intervention: Routine postoperative oral nutritional supplements (ONS) will be provided, and patients with metabolic diseases such as diabetes will undergo strict glycemic control. Psychological intervention: Patients with a Hospital Anxiety and Depression Scale (HADS) score ≥ 8 will receive cognitive behavioral therapy (CBT), and those with a HADS score ≥ 11 will be referred for psychological consultation. Exercise intervention: Postoperative rehabilitation training will be guided according to different postoperative periods.During the study period, the incidence of complications within 30 days postoperatively and quality of postoperative recovery were statistically analyzed, among other outcomes.

Interventions

COMBINATION_PRODUCTEarly structured postoperative intervention encompassing nutrition, psychology, and exercise

Nutritional intervention: Routine postoperative oral nutritional supplements (ONS) will be provided, and patients with metabolic diseases such as diabetes will undergo strict glycemic control. Psychological intervention: Patients with a Hospital Anxiety and Depression Scale (HADS) score ≥ 8 will receive cognitive behavioral therapy (CBT), and those with a HADS score ≥ 11 will be referred for psychological consultation. Exercise intervention: Postoperative rehabilitation training will be guided according to different postoperative periods.

Sponsors

Qilu Hospital of Shandong University
Lead SponsorOTHER
Linyi People's Hospital
CollaboratorOTHER
Liaocheng People's Hospital
CollaboratorOTHER
Yantai Yuhuangding Hospital
CollaboratorOTHER
Central Hospital of Zibo
CollaboratorOTHER
Weifang People's Hospital
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-80 years; * Histologically confirmed adenocarcinoma by preoperative pathology; * Completed preoperative neoadjuvant therapy without obvious immune-related adverse events (irAEs); * Patients with ycT3-4N+Mx disease deemed surgically resectable based on evaluation by gastroscopy, CT, PET-CT, and other imaging modalities; * Signed informed consent and voluntary participation in this study; * Standard ERAS (Enhanced Recovery After Surgery) management during the - perioperative period, with postoperative hospital stay ≤7 days.

Exclusion criteria

* Patients with central nervous system diseases or psychiatric disorders; * Patients with severe diseases of other organ systems; * Patients with recurrent infectious diseases or severe comorbidities; * Patients requiring synchronous surgery for other diseases; * Patients undergoing emergency surgery; * Patients who developed any complication during hospitalization.

Design outcomes

Primary

MeasureTime frameDescription
incidence of complications within 30 days postoperatively30 days after operationThe incidence of complications within 30 days postoperatively was calculated as the number of patients who developed complications within 30 days after surgery divided by the total number of patients in that group.
Postoperative recovery qualityBaseline (Day of Discharge) and POD 30(30 days after surgery)Postoperative recovery quality was assessed using The 15-item Quality of Recovery Score scale, with a maximum score of 150 points and a minimum score of 0 points, where higher scores indicate better postoperative recovery quality

Secondary

MeasureTime frameDescription
Readmission or emergency department visit rate within 30 days postoperatively30 days after surgeryThe rate of Readmission or emergency department visit within 30 days postoperatively was calculated as the number of patients who was readmitted or visited emergency department within 30 days after surgery divided by the total number of patients in that group.
Time interval between surgery and initiation of adjuvant chemotherapy6 month after surgeryThe time interval was calculated as the number of days from postoperative day 1 to the start of adjuvant chemotherapy.
Completion rate of postoperative chemotherapy / Adherence to adjuvant chemotherapy6 month after surgeryThe completion rate of postoperative chemotherapy was calculated as the number of chemotherapy cycles actually completed divided by the number of chemotherapy cycles planned.
Grading of chemotherapy-related adverse events6 month after surgeryIt was evaluated by CTCAE version 5.0,with severity classified from Grade 1 (mild) to Grade 5 (death).
Postoperative quality of life scoreBaseline (Day of Discharge) and POD 30(30 days after surgery)The EORTC Quality of Life Questionnaire for Gastric Cancer (C30 + STO22) questionaire was used to evaluate quality of postoperative recovery, all scales range from 0 to 100. For global health status, higher scores indicate better outcomes; for all functioning and symptom scales in both questionnaires, higher scores indicate worse outcomes.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026